The mortality rates for endocrine, nutritional, and metabolic diseases vary significantly across countries. In 2023, Mexico reported the highest death toll at 152.51 thousand, while Iceland had the lowest at 0.055 thousand. Countries like Costa Rica and Estonia saw significant year-on-year increases, at 21.09% and 18.03%, respectively. In contrast, Slovakia experienced a decline of 2.56%. Over the past five years, these rates have shown varying degrees of increase, with factors such as healthcare advancements and public health initiatives influencing trends.
Future trends to watch include the impact of improved healthcare systems and policies aimed at prevention and management. There is an expected continuation of declining rates in developed countries, while emerging economies might see fluctuating trends due to economic and healthcare system variables.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Mexico | 152,510 | 2023 | +3.7% | +5.91% | View data |
| 2 | 2 Brazil | 98,410 | 2023 | +2.02% | +3.88% | View data |
| 3 | 3 Germany | 37,300 | 2023 | +0.91% | +1.49% | View data |
| 4 | 4 South Africa | 35,230 | 2023 | +1.32% | +1.43% | View data |
| 5 | 5 Japan | 22,990 | 2023 | +0.77% | +0.31% | View data |
| 6 | 6 Colombia | 17,260 | 2023 | +6.59% | +10.45% | View data |
| 7 | 7 Spain | 15,320 | 2023 | +0.63% | +2.62% | View data |
| 8 | 8 Peru | 14,040 | 2023 | +9.75% | +12.24% | View data |
| 9 | 9 Poland | 13,980 | 2023 | +2.54% | +7.71% | View data |
| 10 | 10 Argentina | 13,290 | 2023 | +1.14% | +1.32% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...